Per ola carlsson

Per-Ola Carlsson

Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes

Lundkvist, Per; Grönberg, Annika; Carlsson, Per-Ola; Ludvigsson, Johnny et al.

Ingår i BMJ Open Diabetes Research & Care,

GABA-mediated inhibition of human CD4⁺ T cell functions is enhanced by insulin but impaired by high glucose levels

Jin, Zhe; Hammoud, Hayma; Bhandage, Amol; Korol, Sergiy Vasylyovych et al.

Ingår i EBioMedicine,

Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes

Dawnbringer, Jeanie; Hill, Henrik; Lundgren, Markus; Catrina, Sergiu-Bogdan et al.

Ingår i BMJ Open Diabetes Research & Care,

Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.

Wernroth, Lisa; Kennedy, Beatrice; Fall, Katja; Nguyen, Diem et al.

Ingår i Diabetologia,

Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets

Thorngren, Julia; Brboric, Anja; Vasylovska, Svitlana; Hjelmqvist, Daisy et al.

Ingår i Diabetes, s. ,

An insulin hypersecretion phenotype precedes pancreatic beta cell failure in MODY3 patient-specific cells

Per-Ola Carlsson

Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes

Lundkvist, Per; Grönberg, Annika; Carlsson, Per-Ola; Ludvigsson, Johnny et al.

Part of BMJ Open Diabetes Research & Care,

GABA-mediated inhibition of human CD4⁺ T fängelse functions fryst vatten enhanced bygd insulin but impaired bygd high glucose levels

Jin, Zhe; Hammoud, Hayma; Bhandage, Amol; Korol, Sergiy Vasylyovych et al.

Part of EBioMedicine,

Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes

Dawnbringer, Jeanie; Hill, Henrik; Lundgren, Markus; Catrina, Sergiu-Bogdan et al.

Part of BMJ Open Diabetes Research & Care,

Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.

Wernroth, Lisa; Kennedy, Beatrice; Fall, Katja; Nguyen, Diem et al.

Part of Diabetologia,

Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets

Thorngren, Julia; Brboric, Anja; Vasylovska, Svitlana; Hjelmqvist, Daisy et al.

Part of Diabetes, p. ,

An insulin hypersecretion phenotype precedes pancreatic beta cell failure in MODY3 patient-specific cells

Creating knowledge from diabetes data

Our co-founder and CMO, Professor Per-Ola Carlsson, is a leading researcher in the field of type 1 diabetes. His cutting-edge research explores the potential of genetically modified, hypoimmune insulin-producing cells from the Islets of Langerhans as a cure for type 1 diabetes. Here is what he has to say about his research:

“We’ve demonstrated that genetically modified islet cells can safely survive and produce insulin in people with type 1 diabetes-without the need for immunosuppression. These early results are a major step in our research for a cure.”

While the search for a cure continues, Professor Carlsson is also dedicated to improving healthcare:

“My long-term goal is to be able to bring a cure for type 1 diabetes but in the meantime, I strive to improve the clinical management of diabetes and daily life for everyone living with diabetes by developing digital solutions that can automate the interpretation of diabetes data.”